Canakinumab (Anti-IL-1b)

Synonyms: Ilaris

Canakinumab (Anti-IL-1b) is a recombinant human anti-IL-1β monoclonal antibody targeting IL-1β and neutralizing IL-1β signaling. It can be used in treatment of disorders of autoimmune origin like familial mediterranean fever, mevalonate kinase deficiency, tumor necrosis factor receptor-associated periodic syndrome (TRAPS). MW :145.5 KD.

Canakinumab (Anti-IL-1b)

Purity & Quality Control

Batch: A244601 Purity: 99% Protein concentration: 9.94mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Canakinumab (Anti-IL-1b) is a recombinant human anti-IL-1β monoclonal antibody targeting IL-1β and neutralizing IL-1β signaling. It can be used in treatment of disorders of autoimmune origin like familial mediterranean fever, mevalonate kinase deficiency, tumor necrosis factor receptor-associated periodic syndrome (TRAPS). MW :145.5 KD.

Product Details

CAS No. 914613-48-2
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Canakinumab (Anti-IL-1b) | Canakinumab (Anti-IL-1b) supplier | purchase Canakinumab (Anti-IL-1b) | Canakinumab (Anti-IL-1b) cost | Canakinumab (Anti-IL-1b) manufacturer | order Canakinumab (Anti-IL-1b) | Canakinumab (Anti-IL-1b) distributor